Venture Capital stories
The cash will help Cellares build out its European factory network for cell therapies as it eyes commercial-scale operations and a 2027 IPO.
Institutional investors will now get faster, tailored analysis on technology disruption and AI adoption as Sentinel Global widens access to Sentinel Labs.
Pressure is mounting on AI groups to prove users will keep paying, after Plaud said recurring revenue hit USD $100 million in two years.
The funding values the cybersecurity group at USD $12 billion as enterprises race to secure data exposed to AI tools and agents.
Deep tech accounted for nearly two-thirds of Swiss venture capital last year, as record funding and foreign backing lifted the market.
Backed by Windward, the London-based start-up aims to speed AI infrastructure delivery across EMEA as demand outpaces new capacity.
The deal should help the European consultancy expand as demand grows for data analytics and AI advice across financial services and retail.
The deal values the Finnish satellite intelligence group at more than EUR 10 billion as governments step up demand for sovereign space systems.
Restaurants can tap millions more diners as EatClub's offers move into CommBank's app, targeting quieter service periods.
Backing will fund trials, regulatory work and prototype development as Zuuka targets US demand for home-based insulin delivery.
The listing should speed procurement for cloud customers as employers face rising risks from impersonation, fraud and stolen credentials.
The funding underscores investor demand for AI-focused cybersecurity tools as enterprises face new endpoint risks from human users and agents.
Australia has emerged as a bigger draw for Indian tech workers as US visa curbs and other immigration crackdowns reshape hiring.
Rising data centre power demand is pushing Orbital to test orbit-based AI compute as it prepares a Pathfinder mission for 2027.
The insurer will use Sonder's round-the-clock mental health, medical and safety service to help customers during severe weather and major incidents.
Australian insurtechs will gain a free route to pitch insurers and investors, with the winner earning an expenses-paid trip to Las Vegas.
The Bengaluru firm is adding senior firepower as demand grows for cross-border deal advice paired with execution support.
Funding will back trials and regulatory work as the New Zealand start-up aims to bring a smaller, reusable insulin device to the US market.
British founders risk losing advanced technologies to overseas backers as support dries up after prototypes are proven.
The round values the sovereign AI start-up at USD $1.5 billion as it seeks funding for research and compute to expand across key sectors.